NEVVI Medicare utilization intelligence

← back

MURPHY, JENNIFERM.D. NPI 1639149461 Clinician

Rheumatology · SUMMERVILLE, SC

Specialty Rheumatology — from billed Medicare claims
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location SUMMERVILLE, SC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 43 codes billed · 151,729 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ARTICULARIS HEALTHCARE GROUP INC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-09

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
J0490 Injection, belimumab, 10 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J9312 Injection, rituximab, 10 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
85652 Red blood cell sedimentation rate, to detect inflammation, automated
86140 Measurement c-reactive protein for detection of infection or inflammation
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
36415 Insertion of needle into vein for collection of blood sample
73120 X-ray of hand, 2 views
86235 Measurement of antibody for assessment of autoimmune disorder, any method
83516 Analysis of substance using immunoassay technique, multiple step method
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3489 Injection, zoledronic acid, 1 mg
86160 Measurement of complement (immune system proteins), antigen,
96415 Administration of chemotherapy into vein, each additional hour
96375 Injection of additional new drug or substance into vein
86200 Measurement of antibody for rheumatoid arthritis assessment
86431 Rheumatoid factor level
73620 X-ray of foot, 2 views
84550 Uric acid level, blood
86038 Screening test for autoimmune disorder
73560 X-ray of knee, 1-2 views
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82306 Vitamin d-3 level
82550 Creatine kinase (cardiac enzyme) level, total
86225 Measurement of dna antibody, native or double stranded
86226 Measurement of dna antibody, single stranded
86480 Tuberculosis test, gamma interferon
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
72100 X-ray of lower and sacral spine, 2-3 views

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.